02181 MABPHARM-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.81X | Oper Margin | 2.3% |
|---|---|---|---|
| LT Debt/Equity | 59.1% | Net Margin | 8.8% |
| Total Debt/Equity | 207.7% | Return on Equity | 36.3% |
| Price/Book | 11.76X | Return on Assets | 5.0% |
| (HKD 0.500) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 63.59 | -136.07 | -230.75 | -236.37 | -356.83 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +146.7 | +41.0 | +2.4 | +33.8 | -62.9 |
| Earnings Per Share (HKD) | 0.015 | -0.033 | -0.056 | -0.057 | -0.087 |
| Earnings Per Share Growth (%) | +146.7 | +41.1 | +2.3 | +33.8 | -62.9 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 32.47 | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.043 | 0.023 | 0.055 | 0.109 | 0.179 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 646.095 | 258.228 | +150.2 | 87.161 |
| Operating Result | 3.237 | -127.947 | -102.5 | -209.356 |
| Profit Before Taxation | 4.16 | -127.947 | -103.3 | -209.356 |
| Taxation | -52.973 | 0 | N/A | 0 |
| Profit /( Loss) After Taxation | 57.133 | -127.947 | -144.7 | -209.356 |
| Net Profit | 57.133 | -127.947 | -144.7 | -209.356 |
| Earnings Per Share () | 0.0154 | -0.0330 | -146.7 | -0.0560 |
| Announcement Date | 2026-03-26 | 2025-03-26 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
